Old line) revealed significantly shortened patient survival times if compared to those with low ADAM9 expression (dotted line).<p><b>Copyright information:</b></p><p>Taken from "ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression"</p><p>http://www.biomedcentral.com/1471-2407/8/179</p><p>BMC Cancer 2008;8():179-179.</p><p>Published online 26 Jun 2008</p><p>PMCID:PMC2442841.</p><p></p
